CA2796213A1 - Organic peroxide compounds for microorganism inactivation - Google Patents
Organic peroxide compounds for microorganism inactivation Download PDFInfo
- Publication number
- CA2796213A1 CA2796213A1 CA2796213A CA2796213A CA2796213A1 CA 2796213 A1 CA2796213 A1 CA 2796213A1 CA 2796213 A CA2796213 A CA 2796213A CA 2796213 A CA2796213 A CA 2796213A CA 2796213 A1 CA2796213 A1 CA 2796213A1
- Authority
- CA
- Canada
- Prior art keywords
- composition
- solution
- organic peroxide
- 6alkyl
- multifunctional organic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- -1 Organic peroxide compounds Chemical class 0.000 title claims 10
- 244000005700 microbiome Species 0.000 title claims 8
- 230000002779 inactivation Effects 0.000 title claims 2
- 150000001451 organic peroxides Chemical class 0.000 claims abstract 27
- 229910052799 carbon Inorganic materials 0.000 claims abstract 9
- 108020004707 nucleic acids Proteins 0.000 claims abstract 5
- 150000007523 nucleic acids Chemical class 0.000 claims abstract 5
- 102000039446 nucleic acids Human genes 0.000 claims abstract 5
- 238000000034 method Methods 0.000 claims 63
- 239000000203 mixture Substances 0.000 claims 28
- 239000000243 solution Substances 0.000 claims 27
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 10
- 229910052739 hydrogen Inorganic materials 0.000 claims 8
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims 7
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 6
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims 5
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 claims 5
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 5
- 125000003320 C2-C6 alkenyloxy group Chemical group 0.000 claims 5
- 125000003118 aryl group Chemical group 0.000 claims 5
- 125000001072 heteroaryl group Chemical group 0.000 claims 5
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims 5
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 5
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 claims 2
- 125000006603 (C1-C3) alkylaminosulfonyl group Chemical group 0.000 claims 2
- 125000006595 (C1-C3) alkylsulfinyl group Chemical group 0.000 claims 2
- 125000006594 (C1-C3) alkylsulfony group Chemical group 0.000 claims 2
- 125000006274 (C1-C3)alkoxy group Chemical group 0.000 claims 2
- 125000004454 (C1-C6) alkoxycarbonyl group Chemical group 0.000 claims 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims 2
- 241000700605 Viruses Species 0.000 claims 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 2
- 238000004113 cell culture Methods 0.000 claims 2
- 239000003638 chemical reducing agent Substances 0.000 claims 2
- 125000004093 cyano group Chemical group *C#N 0.000 claims 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 2
- 150000002978 peroxides Chemical group 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 125000006656 (C2-C4) alkenyl group Chemical group 0.000 claims 1
- XYFYIMMQLFFGKB-UHFFFAOYSA-N 1,1,5,5-tetrahydroperoxypentane Chemical compound OOC(OO)CCCC(OO)OO XYFYIMMQLFFGKB-UHFFFAOYSA-N 0.000 claims 1
- QXMZVCDJORAEQI-UHFFFAOYSA-N 1,1-dihydroperoxybutane Chemical compound CCCC(OO)OO QXMZVCDJORAEQI-UHFFFAOYSA-N 0.000 claims 1
- KVFLZSZJBRWQJK-UHFFFAOYSA-N 1,1-dihydroperoxyethane Chemical compound OOC(C)OO KVFLZSZJBRWQJK-UHFFFAOYSA-N 0.000 claims 1
- LPZSIYDMHWOREJ-UHFFFAOYSA-N 1,1-dihydroperoxypropane Chemical compound CCC(OO)OO LPZSIYDMHWOREJ-UHFFFAOYSA-N 0.000 claims 1
- GIHSGBFMYFAEDX-UHFFFAOYSA-N 2,2-dihydroperoxybutane Chemical compound CCC(C)(OO)OO GIHSGBFMYFAEDX-UHFFFAOYSA-N 0.000 claims 1
- KJTGWWIZKOWELB-UHFFFAOYSA-N 3,7-dihydroperoxydioxepane Chemical compound OOC1CCCC(OO)OO1 KJTGWWIZKOWELB-UHFFFAOYSA-N 0.000 claims 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 1
- 108020004414 DNA Proteins 0.000 claims 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- 239000007864 aqueous solution Substances 0.000 claims 1
- 229960005070 ascorbic acid Drugs 0.000 claims 1
- 235000010323 ascorbic acid Nutrition 0.000 claims 1
- 239000011668 ascorbic acid Substances 0.000 claims 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 1
- 108091092356 cellular DNA Proteins 0.000 claims 1
- 239000007795 chemical reaction product Substances 0.000 claims 1
- GOQBCAPQQJUCOC-UHFFFAOYSA-N dihydroperoxymethane Chemical compound OOCOO GOQBCAPQQJUCOC-UHFFFAOYSA-N 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
- 239000001301 oxygen Substances 0.000 claims 1
- 125000002081 peroxide group Chemical group 0.000 claims 1
- 239000000047 product Substances 0.000 claims 1
- 230000000937 inactivator Effects 0.000 abstract 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 230000000593 degrading effect Effects 0.000 abstract 1
- 230000002906 microbiologic effect Effects 0.000 abstract 1
- 229960004854 viral vaccine Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N31/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
- A01N31/02—Acyclic compounds
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N35/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having two bonds to hetero atoms with at the most one bond to halogen, e.g. aldehyde radical
- A01N35/02—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having two bonds to hetero atoms with at the most one bond to halogen, e.g. aldehyde radical containing aliphatically bound aldehyde or keto groups, or thio analogues thereof; Derivatives thereof, e.g. acetals
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/02—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
- A01N43/24—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with two or more hetero atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12061—Methods of inactivation or attenuation
- C12N2720/12063—Methods of inactivation or attenuation by chemical treatment
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16061—Methods of inactivation or attenuation
- C12N2760/16063—Methods of inactivation or attenuation by chemical treatment
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16161—Methods of inactivation or attenuation
- C12N2760/16163—Methods of inactivation or attenuation by chemical treatment
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Plant Pathology (AREA)
- Dentistry (AREA)
- Agronomy & Crop Science (AREA)
- Environmental Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pest Control & Pesticides (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Polymerization Catalysts (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US39511710P | 2010-05-06 | 2010-05-06 | |
| US61/395,117 | 2010-05-06 | ||
| PCT/IB2011/001394 WO2011138682A2 (en) | 2010-05-06 | 2011-05-06 | Organic peroxide compounds for microorganism inactivation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2796213A1 true CA2796213A1 (en) | 2011-11-10 |
Family
ID=44532956
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2796213A Abandoned CA2796213A1 (en) | 2010-05-06 | 2011-05-06 | Organic peroxide compounds for microorganism inactivation |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US9426989B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2566323A2 (cg-RX-API-DMAC7.html) |
| JP (1) | JP6072677B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20130079398A (cg-RX-API-DMAC7.html) |
| CN (1) | CN102946727B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2011249487C1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112012028146A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2796213A1 (cg-RX-API-DMAC7.html) |
| EA (1) | EA201291179A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX343948B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2011138682A2 (cg-RX-API-DMAC7.html) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110804641A (zh) * | 2019-09-04 | 2020-02-18 | 中国农业科学院兰州兽医研究所 | 一种比较分析不同牛支原体菌株毒力的方法 |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8883848B2 (en) | 2011-07-14 | 2014-11-11 | Ecolab Usa Inc. | Enhanced microbial peracid compositions and methods of use at reduced temperatures in aseptic cleaning |
| US8906963B2 (en) | 2011-07-14 | 2014-12-09 | Ecolab Usa Inc | Deodorization of peracids |
| GB2495341B (en) | 2011-11-11 | 2013-09-18 | Novartis Ag | Fermentation methods and their products |
| ITUA20162517A1 (it) * | 2016-04-12 | 2017-10-12 | Andrea Fantozzi | Composizione per la conservazione/fissazione di materiale biologico |
| ES2991988T3 (es) | 2017-10-30 | 2024-12-05 | Takeda Pharmaceuticals Co | Detergentes compatibles con el medio ambiente para la inactivación de virus con envoltura lipídica |
| KR20220098370A (ko) | 2019-11-07 | 2022-07-12 | 세퀴러스 유케이 리미티드 | 감소된 입자 크기를 가지는 바이러스 백신을 제조하기 위한 조성물 및 방법 |
Family Cites Families (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL288026A (cg-RX-API-DMAC7.html) | 1963-01-16 | |||
| US3560395A (en) | 1968-09-12 | 1971-02-02 | Pennwalt Corp | Aqueous ketone peroxide-hydrogen peroxide composition |
| US4060644A (en) * | 1976-02-09 | 1977-11-29 | Interox Chemicals Limited | Bleaching |
| DE2933498A1 (de) * | 1979-08-18 | 1981-04-09 | Dr.rer.nat. Hans-Dieter 4234 Alpen Deppe | Chemothermisches desinfektions- und sterilisationsverfahren |
| PH25669A (en) | 1985-12-19 | 1991-09-04 | Padmini Sampathkumar | Anaerobe-selective antibacterial compositions, methods |
| EP0461700A1 (en) * | 1990-06-12 | 1991-12-18 | Akzo Nobel N.V. | Aqueous disinfectant compositions, and concentrates for preparing the same |
| US5437868A (en) | 1991-07-23 | 1995-08-01 | Ecolab Inc. | Peroxyacid antimicrobial composition |
| GB9222561D0 (en) * | 1992-10-27 | 1992-12-09 | Ici Plc | Macromolecular degradation |
| US5824536A (en) * | 1994-08-23 | 1998-10-20 | St. Jude Children's Research Hospital | Influenza virus replicated in mammalian cell culture and vaccine production |
| FR2738127B1 (fr) | 1995-08-30 | 1998-03-27 | Oreal | Applicateur de mascara |
| DE19612966B4 (de) | 1996-04-01 | 2009-12-10 | Novartis Vaccines And Diagnostics Gmbh & Co. Kg | MDCK-Zellen und Verfahren zur Vermehrung von Influenzaviren |
| GB9612035D0 (en) * | 1996-06-08 | 1996-08-07 | Oilfield Chemical Additives Li | Method of inhibiting reservoir souring by bacteria |
| DE19817743A1 (de) | 1998-04-21 | 1999-10-28 | Binker Materialschutz Gmbh | Materialschutzmittel |
| AU758625B2 (en) * | 1998-08-20 | 2003-03-27 | Ecolab Inc. | The treatment of meat products |
| DE60036952T2 (de) | 1999-09-24 | 2008-08-07 | Glaxosmithkline Biologicals S.A. | Influenzavirus-impfstoffzusammensetzung zur nasalen anwendung |
| AU2001236042B9 (en) | 2000-03-03 | 2006-06-29 | Juridical Foundation The Chemo-Sero-Therapeutic Research Institute | Cell usable in serum-free culture and suspension culture and process for producing virus for vaccine by using the cell |
| FR2808803B1 (fr) | 2000-05-11 | 2004-12-10 | Agronomique Inst Nat Rech | Cellules es modifiees et gene specifique de cellules es |
| GB0024089D0 (en) | 2000-10-02 | 2000-11-15 | Smithkline Beecham Biolog | Novel compounds |
| US20020107288A1 (en) | 2000-12-08 | 2002-08-08 | Singh Waheguru Pal | Methods of sterilizing with dipercarboxylic acids |
| US7316824B2 (en) * | 2000-12-15 | 2008-01-08 | Ecolab Inc. | Method and composition for washing poultry during processing |
| WO2002067983A1 (en) | 2001-02-23 | 2002-09-06 | Glaxosmithkline Biologicals S.A. | Novel vaccine |
| DK1361890T3 (da) | 2001-02-23 | 2011-06-27 | Glaxosmithkline Biolog Sa | Influenzavaccineformuleringer til intradermal indgift |
| MY134424A (en) | 2001-05-30 | 2007-12-31 | Saechsisches Serumwerk | Stable influenza virus preparations with low or no amount of thiomersal |
| US20030012804A1 (en) * | 2001-06-22 | 2003-01-16 | Aquacide And Use | Aquacide and use |
| JPWO2003014338A1 (ja) * | 2001-08-02 | 2004-11-25 | アンジェスＭｇ株式会社 | 不活性化ウイルスエンベロープの製造方法 |
| DE10144906B4 (de) | 2001-09-12 | 2013-11-28 | Novartis Vaccines And Diagnostics Gmbh | Verfahren zur großtechnischen Herstellung von Impfstoffen |
| DE10144903A1 (de) | 2001-09-12 | 2003-03-27 | Chiron Behring Gmbh & Co | Vermehrung von Viren in Zellkultur |
| FR2832423B1 (fr) | 2001-11-22 | 2004-10-08 | Vivalis | Systeme d'expression de proteines exogenes dans un systeme aviaire |
| CN1194984C (zh) | 2002-02-04 | 2005-03-30 | 中国农业科学院植物保护研究所 | 一种抗生素及其制备方法和应用 |
| FR2836924B1 (fr) | 2002-03-08 | 2005-01-14 | Vivalis | Lignees de cellules aviaires utiles pour la production de substances d'interet |
| JP4299514B2 (ja) | 2002-08-29 | 2009-07-22 | 長谷川香料株式会社 | 抗菌抗カビ剤 |
| DE10306018A1 (de) * | 2003-02-13 | 2004-09-09 | Siemens Ag | Analyse- und Diagnostikinstrument |
| EP1637168B1 (en) | 2003-04-16 | 2009-01-21 | Neochemical Desarrollos Avanzados, S.A. | Use of a dialkylketone peroxide as biocidal, sterilizing, antiseptic, disinfecting and anti-parasitic agent |
| EP1528101A1 (en) | 2003-11-03 | 2005-05-04 | ProBioGen AG | Immortalized avian cell lines for virus production |
| WO2005113756A1 (en) | 2004-05-14 | 2005-12-01 | Glaxosmithkline Biologicals S.A. | Method |
| NZ551640A (en) | 2004-05-20 | 2010-05-28 | Id Biomedical Corp | Process for the production of an influenza vaccine |
| CA2592120A1 (en) | 2004-12-23 | 2006-07-06 | Medimmune Vaccines, Inc. | Non-tumorigenic mdck cell line for propagating viruses |
| GB0505909D0 (en) | 2005-03-23 | 2005-04-27 | Univ Leeds | Formulations |
| FR2884255B1 (fr) | 2005-04-11 | 2010-11-05 | Vivalis | Utilisation de lignees de cellules souches aviaires ebx pour la production de vaccin contre la grippe |
| ES2423663T3 (es) * | 2005-08-08 | 2013-09-23 | Oregon Health And Science University | Inactivación de patógenos con peróxido de hidrógeno para la producción de vacunas |
| WO2007042175A1 (en) | 2005-10-07 | 2007-04-19 | Dsm Ip Assets B.V. | Peroxide decomposition catalyst |
| PL2301572T3 (pl) | 2005-11-01 | 2015-02-27 | Novartis Influenza Vaccines Marburg Gmbh | Szczepionki wirusowe otrzymane z komórek o niskim poziomie pozostałości DNA komórkowego |
| ES2286949B1 (es) | 2006-05-26 | 2008-11-01 | Braulio Peña Rodriguez | Uso de combinaciones de peroxido de metil etil cetona por pulverizacion. |
| SG177141A1 (en) | 2006-12-06 | 2012-01-30 | Novartis Ag | Vaccines including antigen from four strains of influenza virus |
-
2011
- 2011-05-06 EA EA201291179A patent/EA201291179A1/ru unknown
- 2011-05-06 AU AU2011249487A patent/AU2011249487C1/en not_active Ceased
- 2011-05-06 CA CA2796213A patent/CA2796213A1/en not_active Abandoned
- 2011-05-06 KR KR1020127030049A patent/KR20130079398A/ko not_active Withdrawn
- 2011-05-06 CN CN201180022567.3A patent/CN102946727B/zh not_active Expired - Fee Related
- 2011-05-06 BR BR112012028146A patent/BR112012028146A2/pt not_active IP Right Cessation
- 2011-05-06 US US13/696,595 patent/US9426989B2/en not_active Expired - Fee Related
- 2011-05-06 JP JP2013508577A patent/JP6072677B2/ja not_active Expired - Fee Related
- 2011-05-06 EP EP11733909A patent/EP2566323A2/en not_active Withdrawn
- 2011-05-06 WO PCT/IB2011/001394 patent/WO2011138682A2/en not_active Ceased
- 2011-05-06 MX MX2012012335A patent/MX343948B/es active IP Right Grant
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110804641A (zh) * | 2019-09-04 | 2020-02-18 | 中国农业科学院兰州兽医研究所 | 一种比较分析不同牛支原体菌株毒力的方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102946727A (zh) | 2013-02-27 |
| AU2011249487C1 (en) | 2015-05-14 |
| WO2011138682A8 (en) | 2012-07-19 |
| MX2012012335A (es) | 2012-11-21 |
| JP2013528586A (ja) | 2013-07-11 |
| EA201291179A1 (ru) | 2013-04-30 |
| EP2566323A2 (en) | 2013-03-13 |
| BR112012028146A2 (pt) | 2015-09-15 |
| US20130149194A1 (en) | 2013-06-13 |
| MX343948B (es) | 2016-11-30 |
| AU2011249487A1 (en) | 2012-09-27 |
| JP6072677B2 (ja) | 2017-02-01 |
| AU2011249487B2 (en) | 2014-10-02 |
| US9426989B2 (en) | 2016-08-30 |
| WO2011138682A3 (en) | 2012-03-15 |
| WO2011138682A2 (en) | 2011-11-10 |
| CN102946727B (zh) | 2015-08-19 |
| KR20130079398A (ko) | 2013-07-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2796213A1 (en) | Organic peroxide compounds for microorganism inactivation | |
| ES2532015T3 (es) | Método para la producción de vectores adenovíricos | |
| ES2578514T3 (es) | Método para la producción de vectores adenovíricos | |
| Stoenner | Biology of Borrelia hermsii in Kelly medium | |
| EA200801221A1 (ru) | Вирусные вакцины, полученные из клеток, с низкими уровнями остаточной клеточной днк | |
| JP2013528586A5 (cg-RX-API-DMAC7.html) | ||
| Kiesslich et al. | Bioreactor production of rVSV‐based vectors in Vero cell suspension cultures | |
| CN113528466A (zh) | 包含外源抗原的人巨细胞病毒 | |
| CN111172119A (zh) | 具有宽裂解谱的新副溶血弧菌噬菌体、其特异性引物及其应用 | |
| CN111135184A (zh) | GS-441524在制备新型冠状病毒SARS-CoV-2抑制剂中的应用 | |
| CN104178459A (zh) | 一种无血清悬浮培养狂犬病毒的方法 | |
| WO2011003062A2 (en) | Probiotic compositions and processes thereof | |
| DK2310510T3 (en) | IDNA vaccines and methods for their use | |
| CN114990075B (zh) | 一株可适用于人用疫苗细胞基质培养的柯萨奇病毒a组10型疫苗株及其应用 | |
| CN107468682B (zh) | 芒果苷在制备抗病毒药物中的应用 | |
| CN112915200A (zh) | 一种三联灭活疫苗及其制备和应用 | |
| WO2008058752A3 (en) | Lentiviral vectors for gene transfer in quiescent (g0) cells | |
| CN113061584A (zh) | 一种能促进腺病毒生长的培养基添加物 | |
| CN106191118B (zh) | 一种慢病毒干扰载体及其构建方法和应用 | |
| CN111235150A (zh) | 用于抑制非洲猪瘟病毒复制的shRNA及其用途 | |
| CN103937759A (zh) | 双羰基还原酶、其编码基因及应用 | |
| TW202444884A (zh) | 含有類菌孢素胺基酸之菌體，及其萃取物之製造方法 | |
| WO2024032360A1 (zh) | 一种牛结节性皮肤病病毒毒株、以及由其制备的灭活疫苗和疫苗的制备方法 | |
| CN102352359A (zh) | 抗猪O型口蹄疫病毒病shRNA设计及载体的构建方法 | |
| IN2014MN02324A (cg-RX-API-DMAC7.html) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20160419 |
|
| FZDE | Discontinued |
Effective date: 20181018 |